4.7 Review

Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open Questions

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Urology & Nephrology

Longitudinal association between dietary protein intake and survival in peritoneal dialysis patients

Shu-Hong Bi et al.

Summary: This study found that a baseline dietary protein intake (DPI) less than 0.60g/kg/day was associated with worse outcomes in peritoneal dialysis (PD) patients. PD patients with a DPI of 0.61-0.79g/kg/day had significantly negative nitrogen balance. There was a longitudinal association between time-dependent DPI and survival in PD patients, with consistently low DPI being correlated with increased death risk.

RENAL FAILURE (2023)

Article Urology & Nephrology

Effect of lanthanum carbonate on the progression of coronary artery calcification in hemodialysis patients: A meta-analysis of randomized controlled trials

Jun-Peng Xu et al.

Summary: Lanthanum carbonate therapy in hemodialysis patients may help slow the progression of coronary artery calcification and left ventricular mass index, reduce serum phosphate, calcium, and FGF23 levels, and decrease the risk of nonfatal cardiovascular events. Further well-designed RCTs are needed for confirmation.

HEMODIALYSIS INTERNATIONAL (2022)

Review Food Science & Technology

Phosphocalcic metabolism and the role of vitamin D, vitamin K2, and nattokinase supplementation

Amin Gasmi et al.

Summary: Calcium is essential for bone health and nerve signaling, while phosphorus is a key component of ATP and helps regulate metabolic energy. Vitamins D and K are crucial for the absorption and excretion of calcium and phosphorus, with vitamin D playing a regulatory role in various bodily functions.

CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION (2022)

Article Urology & Nephrology

Safety and effectiveness of ferric citrate hydrate in serum phosphorus management of patients with chronic kidney disease: a long-term, real-world, observational, post-marketing surveillance study

Keitaro Yokoyama et al.

Summary: This post-marketing surveillance study in Japan involving 2723 CKD patients showed that most patients experienced an increase in iron-related parameters after starting FC treatment, which stabilized after week 36, while serum phosphorus levels immediately decreased and remained lowered for 104 weeks. The study concluded that there were no new safety concerns with long-term FC treatment and that it effectively controlled serum phosphorus levels.

CLINICAL AND EXPERIMENTAL NEPHROLOGY (2022)

Article Biology

Hyperphosphatemia increases inflammation to exacerbate anemia and skeletal muscle wasting independently of FGF23-FGFR4 signaling

Brian Czaya et al.

Summary: Elevated plasma phosphate concentrations can lead to complications such as inflammation, anemia, and skeletal muscle wasting in chronic kidney disease patients. This study found that these complications can also occur in mice with adenine-induced CKD or mice fed a high phosphate diet. However, a low phosphate diet was able to ameliorate anemia and skeletal muscle wasting in a genetic mouse model of CKD. Mechanistic in vitro studies revealed that phosphate elevations induce inflammatory signaling and increase hepcidin expression in hepatocytes. These findings suggest the harmful effects of high phosphate intake, supporting the need to treat hyperphosphatemia in CKD patients and limit phosphate intake in healthy individuals.
Review Biochemistry & Molecular Biology

Mineral Bone Disorders in Kidney Disease Patients: The Ever-Current Topic

Lilio Hu et al.

Summary: Chronic kidney disease (CKD) is a prevalent and complex disease, and chronic kidney disease-mineral bone disorders (CKD-MBD) are complications associated with the progression of CKD. This review focuses on the abnormalities in serum levels of various biomarkers in CKD-MBD and examines the prognostic association between CKD-MBD and the increased risk for cardiovascular events, mortality, and CKD progression. Specific treatments for CKD-MBD are also presented.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Urology & Nephrology

Phosphate Frustration: Treatment Options to Complement Current Therapies

Pablo E. Pergola

Summary: Hyperphosphatemia is a common complication of advanced chronic kidney disease and is difficult to manage with current treatment options. Tenapanor, a new medication that blocks the absorption of phosphate, has shown promise in reducing phosphate levels and may be a potential treatment option for these patients.

INTERNATIONAL JOURNAL OF NEPHROLOGY (2022)

Review Urology & Nephrology

Healthy aging and chronic kidney disease

Reshma Aziz Merchant et al.

Summary: The world population is aging and the prevalence of chronic kidney disease (CKD) is expected to increase. CKD is considered an accelerated aging model and is associated with physical and cognitive decline. Frailty and dementia have a triangular relationship with CKD, sharing common risk factors. It is important to establish a system for preventing CKD, focusing on screening and intervention for frailty, poor appetite, and cognitive impairment.

KIDNEY RESEARCH AND CLINICAL PRACTICE (2022)

Review Urology & Nephrology

On the importance of the interplay of residual renal function with clinical outcomes in end-stage kidney disease

Cem Tanriover et al.

Summary: Chronic kidney disease is a significant public health concern, with increasing numbers of patients progressing to end-stage kidney disease and requiring peritoneal dialysis and hemodialysis. Preserving residual renal function is crucial for improving clinical outcomes and quality of life in these patients. Residual renal function contributes to the wellbeing of end-stage kidney disease patients through various mechanisms and has beneficial effects on inflammation, anemia, malnutrition, diabetes mellitus, obesity, changes in microbiota, and cardiac diseases. Multiple strategies for preserving residual renal function are being investigated through ongoing clinical trials.

JOURNAL OF NEPHROLOGY (2022)

Review Nutrition & Dietetics

Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm

Anjay Rastogi et al.

Summary: In CKD, bone and mineral metabolism becomes dysregulated, leading to high levels of parathyroid hormone and potential issues with phosphorus control. Strategies for controlling hyperphosphatemia in dialysis patients have benefits and limitations, suggesting the need for a more integrated approach incorporating multiple biomarkers and correlation between diet adjustments and medications for improved patient management.

JOURNAL OF RENAL NUTRITION (2021)

Review Urology & Nephrology

Klotho in Clinical Nephrology Diagnostic and Therapeutic Implications

Javier A. Neyra et al.

Summary: Klotho, a membrane protein that serves as a coreceptor for FGF23, is essential for maintaining organ function and preventing multiorgan failure. Systemic Klotho deficiency is commonly associated with kidney diseases. While Klotho shows promise in clinical applications, further research and large prospective human studies are needed to fully understand its diagnostic and therapeutic potential.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Editorial Material Urology & Nephrology

Dietary Therapy for Managing Hyperphosphatemia

Yoko Narasaki et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

Review Nutrition & Dietetics

Vitamin D and cardiovascular health

Fernando de la Guia-galipienso et al.

Summary: The main source of vitamin D in humans is the skin's biosynthesis through sun exposure, with additional intake from foods like fatty fish. Deficiency can lead to global health issues due to inadequate sunlight exposure. Beyond maintaining calcium and phosphorus balance, vitamin D plays key roles in the immune and cardiovascular systems.

CLINICAL NUTRITION (2021)

Article Multidisciplinary Sciences

Peritoneal dialysis modality transition and impact on phosphate and potassium serum levels

Daniela Peruzzo et al.

Summary: This study found that switching between different PD modalities can affect serum levels of phosphate, with CAPD being more effective at controlling phosphate levels than APD. However, the impact on potassium levels was similar across modality switches. Further exploration is needed to fully understand the clinical implications of higher removal of middle size molecules as a result of PD modalities.

PLOS ONE (2021)

Review Nutrition & Dietetics

The Importance of Phosphate Control in Chronic Kidney Disease

Ken Tsuchiya et al.

Summary: CKD-MBD, a series of problems associated with chronic kidney disease, is now being studied in relation to factors such as α-Klotho and FGF23. The importance of phosphate in CKD-MBD is gaining attention, with research focusing on how phosphate metabolism and hyperphosphatemia are involved in the disease.

NUTRIENTS (2021)

Article Urology & Nephrology

Serum phosphate and mortality in incident dialysis patients in Australia and New Zealand

Mark K. Tiong et al.

Summary: The study found that both high and low levels of serum phosphate were independently associated with increased risk of mortality, with a more pronounced association with high serum phosphate and cardiovascular mortality. This association was consistent across patients receiving haemodialysis and peritoneal dialysis treatment.

NEPHROLOGY (2021)

Editorial Material Urology & Nephrology

FOREWORD

Alison Steiber et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2020)

Review Urology & Nephrology

The current and future landscape of dialysis

Jonathan Himmelfarb et al.

NATURE REVIEWS NEPHROLOGY (2020)

Article Multidisciplinary Sciences

Phosphate clearance in peritoneal dialysis

Malgorzata Debowska et al.

SCIENTIFIC REPORTS (2020)

Review Nutrition & Dietetics

Overview of the 2017 KDIGO CKD-MBD Update: Practice Implications for Adult Hemodialysis Patients

Judith Beto et al.

JOURNAL OF RENAL NUTRITION (2019)

Article Urology & Nephrology

Phosphate-Binder Use in US Dialysis Patients: Prevalence, Costs, Evidence, and Policies

Wendy L. St Peter et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2018)

Review Nutrition & Dietetics

Intestinal Phosphorus Absorption in Chronic Kidney Disease

Elizabeth R. Stremke et al.

NUTRIENTS (2018)

Review Endocrinology & Metabolism

Vascular calcification in CKD-MBD: Roles for phosphate, FGF23, and Klotho

Shunsuke Yamada et al.

Article Urology & Nephrology

Solute and Water Transport in Peritoneal Dialysis: A Case-Based Primer

Ramesh Khanna

AMERICAN JOURNAL OF KIDNEY DISEASES (2017)

Article Urology & Nephrology

PHOSPHATE REMOVAL BY PERITONEAL DIALYSIS: THE EFFECT OF TRANSPORTER STATUS AND PERITONEAL DIALYSIS PRESCRIPTION

Cecile Courivaud et al.

PERITONEAL DIALYSIS INTERNATIONAL (2016)

Review Multidisciplinary Sciences

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis

Nathan R. Hill et al.

PLOS ONE (2016)

Article Physiology

Peritoneal dialysis: from bench to bedside and bedside to bench

Jeffrey Perl et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2016)

Review Urology & Nephrology

Phosphate binders for the treatment of chronic kidney disease: role of iron oxyhydroxide

Valeria Cernaro et al.

INTERNATIONAL JOURNAL OF NEPHROLOGY AND RENOVASCULAR DISEASE (2016)

Article Transplantation

Long-term effects of the iron-based phosphate binder, sucroferric oxyhydroxide, in dialysis patients

Juergen Floege et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2015)

Article Cardiac & Cardiovascular Systems

Improving diet recipe and cooking methods attenuates hyperphosphatemia in patients undergoing peritoneal dialysis

N. Jiang et al.

NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2015)

Editorial Material Nutrition & Dietetics

Phosphorus

Mona S. Calvo et al.

ADVANCES IN NUTRITION (2015)

Article Urology & Nephrology

Ferric Citrate Controls Phosphorus and Delivers Iron in Patients on Dialysis

Julia B. Lewis et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)

Editorial Material Pharmacology & Pharmacy

The future of phosphate binders: a perspective on novel therapeutics

Valeria Cernaro et al.

EXPERT OPINION ON INVESTIGATIONAL DRUGS (2014)

Review Urology & Nephrology

Water transport across the peritoneal membrane

Olivier Devuyst et al.

KIDNEY INTERNATIONAL (2014)

Article Nutrition & Dietetics

Assessing the Health Impact of Phosphorus in the Food Supply: Issues and Considerations

Mona S. Calvo et al.

ADVANCES IN NUTRITION (2014)

Review Physiology

A current understanding of vascular calcification in CKD

Neil J. Paloian et al.

AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2014)

Article Urology & Nephrology

Mortality in Kidney Disease Patients Treated with Phosphate Binders: A Randomized Study

Biagio Di Iorio et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)

Article Transplantation

Multimodality vascular imaging in CKD: divergence of risk between measured parameters

William G. Petchey et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2012)

Article Urology & Nephrology

The Role of Phosphorus in the Development and Progression of Vascular Calcification

Jessica Kendrick et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2011)

Article Endocrinology & Metabolism

Effectiveness and Cost-Efficacy of Phosphate Binders in Hemodialysis

Sophie Brunner-Ziegler et al.

ANNALS OF NUTRITION AND METABOLISM (2011)

Article Urology & Nephrology

Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease

Ming Chang Hu et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2011)

Review Urology & Nephrology

Urea and Uremic Solutes: How Does Peritoneal Dialysis Work?

Bert Bammens

SEMINARS IN NEPHROLOGY (2011)

Article Hematology

Phosphate Elimination in Modalities of Hemodialysis and Peritoneal Dialysis

Martin K. Kuhlmann

BLOOD PURIFICATION (2010)

Review Urology & Nephrology

Understanding Sources of Dietary Phosphorus in the Treatment of Patients with Chronic Kidney Disease

Kamyar Kalantar-Zadeh et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)

Article Urology & Nephrology

Serum Phosphorus Concentrations and Arterial Stiffness among Individuals with Normal Kidney Function to Moderate Kidney Disease in MESA

Joachim H. Ix et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Urology & Nephrology

Pill Burden, Adherence, Hyperphosphatemia, and Quality of Life in Maintenance Dialysis Patients

Yi-Wen Chiu et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2009)

Article Transplantation

Efficacy and safety of sevelamer hydrochloride and calcium acetate in patients on peritoneal dialysis

Pieter Evenepoel et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2009)

Article Urology & Nephrology

Peritoneal Phosphate Clearance is Influenced by Peritoneal Dialysis Modality, Independent of Peritoneal Transport Characteristics

Sunil V. Badve et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)

Review Pharmacology & Pharmacy

Emerging drugs for hyperphosphatemia

Guido Bellinghieri et al.

EXPERT OPINION ON EMERGING DRUGS (2007)

Letter Transplantation

Hyperphosphataemia and related mortality

Marlies Noordzij et al.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)

Article Nutrition & Dietetics

Effect of boiling on dietary phosphate and nitrogen intake

A Cupisti et al.

JOURNAL OF RENAL NUTRITION (2006)

Article Urology & Nephrology

Predictors of the rate of decline of residual renal function in incident dialysis patients

MAM Jansen et al.

KIDNEY INTERNATIONAL (2002)

Article Urology & Nephrology

Parathormone secretion in peritoneal dialysis patients with adynamic bone disease

MC Sánchez et al.

AMERICAN JOURNAL OF KIDNEY DISEASES (2000)